Dechra Pharmaceuticals PLC
DCHPF · OTC
6/30/2023 | 12/31/2022 | 6/30/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4 | $3 | $3 | $5 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $0 | $0 |
| Enterprise Value | $4 | $3 | $4 | $6 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 1.8% | 8% | 5.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 55% | 57.9% | 56.1% | 56.8% |
| EBITDA | -$0 | $0 | $0 | $0 |
| % Margin | -4.1% | 12.5% | 17.5% | 19.5% |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -13.1% | 6% | 5% | 12.2% |
| EPS Diluted | -0.44 | 0.199 | 0.16 | 0.38 |
| % Growth | -321.6% | 23.8% | -57.8% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | $0 | $0 |